Key Concepts: Participant Bias, Placebo Effect, and Double-Blind Design

Participant bias and the placebo effect

  • Research participant bias: participants' behavior is influenced by expectations about how they should behave or what is happening in the study.
  • Placebo effect: outcomes driven by participants' expectations rather than the active treatment.
  • Placebo in control group: an inert substance given to control participants so they are treated identically to the experimental group except for the active agent.
  • Purpose: placebo controls for expectancy effects to determine if changes in the experimental group are due to the active drug agent and not to expectations.

Placebo control group and purpose

  • Placebo: harmless substance with no physiological effect used to compare against the active treatment.
  • Control for interpretation: ensures observed differences are attributable to the active agent, not participants’ beliefs about treatment.
  • External validity consideration: if participants volunteer, willingness to participate may affect how generalizable results are to the broader population.

Double-blind design

  • Double-blind: neither the experimenter nor the participants know who is in the experimental vs. control group until results are calculated.
  • Benefit: prevents experimenter cues or participant expectations from influencing outcomes.
  • Outcome focus: helps identify the specific effects of the independent variable from biases related to expectations.

External validity considerations

  • Volunteer bias: differences in willingness to volunteer can limit generalizability of findings.
  • Reflective question: Would you volunteer? How might varying willingness affect external validity?